MDxHealth SA R&D Spending Growth & History (MDXH)

MDxHealth SA's r&d spending was $10.3M for fiscal 2025.

View full MDxHealth SA company overview

MDxHealth SA annual r&d spending history

MDxHealth SA annual r&d spending

Fiscal yearPeriod endedR&D spendingChangeGrowth
20252025-12-31$10.3M−$202,000−1.91%
20242024-12-31$10.6M$4.2M+65.50%
20232023-12-31$6.4M$879,000+15.99%
20222022-12-31$5.5M−$92,000−1.65%
20212021-12-31$5.6M$1.0M+23.02%
20202020-12-31$4.5M−$4.5M−49.51%
20192019-12-31$9.0M

MDxHealth SA r&d spending trends

Over the last five fiscal years, MDxHealth SA's r&d spending increased from $4.5M to $10.3M, a change of $5.8M. The latest reported quarter, Q2 2026, shows $2.0M.

About the metric

What research and development spending means

Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.

Calculation and source

SEC-reported R&D expense

TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review MDxHealth SA source filings ↗

Community posts

It’s quiet here.

No posts about MDXH yet. Start the conversation.

Write the first post